Table 3.

Prevalence of PIPc by indicators of omission of appropriate dispensing

Indicator	No of children who were not prescribed appropriate medication	No of children eligible to be prescribed appropriate medication	Children who were not prescribed appropriate prescription (%)	95% CI
A spacer device should be prescribed at least every 12 months to children under 12 years of age who are prescribed a pressurised metered-dose inhaler	39 945	57 010	70.1	69.4 to 70.8
An emollient should be prescribed to children prescribed greater than one topical corticosteroid in a year	7479	13 953	53.6	52.4 to 54.8
An inhaled corticosteroid should be prescribed to children aged 5–15 years who are prescribed a long-acting beta-2 agonist	18	45	40.0	21.5 to 58.7
An inhaled short-acting beta-2 agonist should be prescribed to children under 5 years of age who are prescribed a leukotriene receptor antagonist	1914	5146	37.2	35.5 to 38.9
An inhaled short-acting beta-2 agonist should be prescribed to all children who are prescribed two or more inhaled corticosteroids	1410	22 492	6.3	5.9 to 6.5